Viewing StudyNCT00387426



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00387426
Status: TERMINATED
Last Update Posted: 2014-05-28
First Post: 2006-10-12

Brief Title: Sunitinib in Treating Patients With Idiopathic Myelofibrosis
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Untreated Hairy Cell Leukemia
Accelerated Phase Chronic Myelogenous Leukemia
Acute Undifferentiated Leukemia
Adult Acute Lymphoblastic Leukemia in Remission
Adult Acute Myeloid Leukemia in Remission
Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities
Adult Acute Myeloid Leukemia With Inv16p13q22
Adult Acute Myeloid Leukemia With t1517q22q12
Adult Acute Myeloid Leukemia With t1616p13q22
Adult Acute Myeloid Leukemia With t821q22q22
Atypical Chronic Myeloid Leukemia BCR-ABL1 Negative
Blastic Phase Chronic Myelogenous Leukemia
Chronic Myelomonocytic Leukemia
Chronic Phase Chronic Myelogenous Leukemia
Mast Cell Leukemia
Meningeal Chronic Myelogenous Leukemia
Primary Myelofibrosis
Progressive Hairy Cell Leukemia Initial Treatment
Prolymphocytic Leukemia
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Acute Myeloid Leukemia
Refractory Chronic Lymphocytic Leukemia
Refractory Hairy Cell Leukemia
Relapsing Chronic Myelogenous Leukemia
Secondary Acute Myeloid Leukemia
Stage I Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia
T-cell Large Granular Lymphocyte Leukemia
Untreated Adult Acute Lymphoblastic Leukemia
Untreated Adult Acute Myeloid Leukemia
Keywords: